VR Adviser, LLC logo

VR Adviser, LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for VR Adviser, LLC with $1.8B in long positions as of Q3 2025, 75% allocated to Healthcare, and 69% concentrated in top 10 positions.

Portfolio Value
$1.8B
Top 10 Concentration
69%
Top Sector
Healthcare (75%)
US Exposure
97%
Market Cap Focus
Mid Cap
Countries
3

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 74.80%Healthcare
Healthcare
74.80%

Industry Breakdown

1 industry across all sectors

Biotechnology: 74.83%Biotechnology
Biotechnology
Healthcare
74.83%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mid Cap ($2B - $10B): 47.04%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 45.14%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 4.79%Nano Cap (< $50M): 0.28%N/A (ETF or Unknown): 2.76%
Mid Cap ($2B - $10B)
47.04%
Small Cap ($300M - $2B)
45.14%
Micro Cap ($50M - $300M)
4.79%
Nano Cap (< $50M)
0.28%
N/A (ETF or Unknown)
2.76%

Portfolio Concentration

Top 10 Holdings %
69.03%
Top 20 Holdings %
90.83%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
97.11%
International
2.89%
Countries
3
Largest Int'l Market
Canada - 1.94%
United States of America
97.11% ($1.7B)
31 holdings
Canada
1.94% ($34.5M)
1 holdings
Netherlands
0.95% ($16.8M)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
9.3 quarters
Avg. Top 20
7 quarters
Avg. All Positions
5.8 quarters
Median Holding Period
5 quarters
Persistence Rate
66.67%
Persistent Holdings Weight
70.5%
Persistent Positions
22
Longest Held
Cogent Biosciences, Inc. Common Stock logo
Cogent Biosciences, Inc. Common StockCOGT - 20 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
1.58%
Avg. Position Weight
3.03%
Largest Position
Apogee Therapeutics, Inc. Common Stock logo
Apogee Therapeutics, Inc. Common StockAPGE - 18.99%
Largest Ownership Stake
Apogee Therapeutics, Inc. Common Stock logo
Apogee Therapeutics, Inc. Common StockAPGE - 14.25%
Avg. Ownership Stake
7.40%
Ownership Stake >5%
19
Ownership Stake >1%
32

Historical (Since Q1 2020)

Avg. New Position
4.83%
Avg. Ownership Stake
6.22%
Largest Position
Aptose Biosciences, Inc. logo
Aptose Biosciences, Inc.APTO - 85.78% (Q1 2021)
Largest Ownership Stake
Surrozen, Inc. Common logo
Surrozen, Inc. CommonSRZN - 19.48% (Q1 2025)

Portfolio Turnover

Current Quarter

Turnover Ratio
7.4%
Value Traded
$131.22M
Positions Added
2
Positions Exited
0

Historical (Since Q1 2020)

Avg. Turnover Ratio
37.2%
Avg. Positions Added
7
Avg. Positions Exited
6
Highest Turnover
335.9%
Q2 2021
Lowest Turnover
3.4%
Q1 2022

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.